Sharescart Research Club logo

Key Financials Snapshot

TTM · Consolidated · ₹ in Cr
Market Cap
₹13641 Cr.
Stock P/E
55.9
P/B
8.3
Current Price
₹1343.2
Book Value
₹ 162.3
Face Value
10
52W High
₹1644.1
52W Low
₹ 1008.8
Dividend Yield
0.26%

RainbowChildrenS Med Overview

Business

Rainbow Children's Medicare Ltd. is an India-based company operating a chain of multi-specialty hospitals primarily focused on pediatric, obstetrics, and gynecology healthcare services. Its core business model involves establishing and managing specialized hospitals that cater specifically to the healthcare needs of children and women, from birth to adolescence and throughout various stages of womanhood, including fertility services. The company makes money by providing a comprehensive range of medical services, including out-patient consultations, in-patient admissions, surgeries, diagnostics, intensive care, pharmacy services, and other allied healthcare services.

Revenue Mix

The company's primary services, which can be considered its key segments, are:

Pediatric Care: Covering various specialties like pediatric intensive care, neonatal intensive care, pediatric cardiology, neurology, nephrology, oncology, and general pediatrics.

Obstetrics & Gynecology: Services include maternal care, high-risk pregnancy management, fertility services, general gynecology, and gynecological surgeries.

Allied Services: Diagnostic services, pharmacy, and other support services that complement the core medical offerings.

Revenue is generated predominantly from in-patient (IPD) and out-patient (OPD) services across these specialities.

Industry

The Indian hospital and healthcare services industry is large, growing, and increasingly sophisticated, driven by rising disposable incomes, health awareness, and insurance penetration. It is characterized by a mix of unorganized standalone facilities and a growing number of organized hospital chains. Rainbow Children's Medicare Ltd. holds a unique and strong position as one of the largest organized and specialized players in the pediatric and maternal care segment. Its niche focus differentiates it from general multi-specialty hospitals, allowing it to build expertise and a reputation for sensitive and specialized care within this high-demand segment.

MOAT

Specialization & Brand Reputation: A focused approach on pediatric and women's healthcare has allowed Rainbow to build deep expertise and a trusted brand, particularly in sensitive areas like neonatal and pediatric intensive care, where parents seek the best possible outcomes. This specialization creates a strong preference among target customers.

Clinical Excellence & Talent: Attracting and retaining highly specialized doctors and medical staff in pediatrics and obstetrics is critical. Rainbow's established network and focus enable it to build and maintain teams of experts, which is a significant barrier for new entrants.

Network Effect (within niche): As the company expands its network of specialized hospitals, it can leverage cross-referrals and centralize certain high-end services, enhancing its operational efficiency and patient access.

Growth Drivers

Demographic Tailwinds: India's large young population and high birth rate provide a substantial and continuous demand pool for pediatric and maternal healthcare.

Under-penetration of Specialized Care: There is a significant gap in organized, high-quality specialized pediatric and women's healthcare across many Indian cities, offering ample room for expansion.

Network Expansion: Opening new hospitals in existing and new Tier-1 and Tier-2 cities is a key growth strategy to tap into unserved markets.

Rising Healthcare Expenditure: Increasing affluence and greater awareness lead to higher out-of-pocket spending and health insurance adoption for quality healthcare.

Focus on Medical Tourism: The specialized nature of Rainbow's services could attract patients from other countries seeking advanced pediatric and maternal care.

Risks

Talent Acquisition & Retention: Shortage of highly specialized medical professionals (pediatricians, neonatologists, obstetricians) and intense competition for talent can drive up costs.

Regulatory Changes: Government interventions on healthcare pricing, land allotment, or quality standards could impact profitability and operational flexibility.

Competition: Increasing competition from other organized hospital chains looking to enter or expand within the specialized mother and child care segment.

High Capital Expenditure: Expansion through new hospital development requires significant capital investment, which can strain finances and impact short-term profitability.

Quality & Reputation Risk: Any lapse in medical quality or patient care across its growing network could severely damage its specialized brand reputation.

Management & Ownership

Rainbow Children's Medicare Ltd. is a promoter-led company, founded by Dr. Ramesh Kancharla, who has extensive experience in the healthcare sector, particularly in pediatric care. The management team generally comprises professionals with medical and administrative backgrounds relevant to hospital operations. The ownership structure includes a significant promoter holding, with a portion of shares publicly listed and held by institutional investors and the public. The promoter-led nature typically implies a strong focus on the core business vision and long-term strategy.

Outlook

Rainbow Children's Medicare benefits from robust demand in the under-penetrated specialized pediatric and maternal healthcare segment in India, driven by favorable demographics and increasing affordability. Its strong brand, clinical expertise, and strategic expansion plans position it well for sustained growth, leveraging its niche advantage to attract patient volumes and potentially improve operating leverage over time. However, the company faces considerable challenges including intense competition for specialized medical talent, the high capital intensity of hospital expansion, and potential regulatory risks. Maintaining consistent quality across a rapidly expanding network is crucial for preserving its trusted brand. While the long-term structural tailwinds for specialized healthcare are strong, significant execution risks and capital commitments mean that growth may come with near-term pressure on profitability and require careful management of resources and quality standards.

RainbowChildrenS Med Share Price

Live · BSE / NSE · Inception: 1998
| |
Volume
Price

Key Financials — Profit & Loss

₹ in Cr · Consolidated · annual

RainbowChildrenS Med Quarterly Results

#(Fig in Cr.) Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026
Net Sales 336 341 330 417 398 370 353 445 445 460
Other Income 9 13 12 11 13 15 20 8 11 5
Total Income 345 354 342 429 411 385 373 453 456 465
Total Expenditure 218 236 236 270 264 255 249 296 298 315
Operating Profit 127 118 106 158 148 129 124 157 157 150
Interest 14 17 18 18 18 18 18 19 20 20
Depreciation 28 32 34 35 35 34 34 36 40 41
Exceptional Income / Expenses 0 0 0 0 0 0 0 0 0 -2
Profit Before Tax 85 69 53 105 94 77 71 102 98 87
Provision for Tax 22 18 14 26 25 20 18 27 24 9
Profit After Tax 63 51 40 79 69 57 54 76 74 78
Adjustments -0 -0 -0 -0 -0 -0 -0 -0 -1 -1
Profit After Adjustments 62 51 40 79 69 56 53 75 73 77
Adjusted Earnings Per Share 6.1 5 3.9 7.8 6.8 5.5 5.3 7.4 7.1 7.6

RainbowChildrenS Med Profit & Loss

#(Fig in Cr.) Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 TTM
Net Sales 321 402 543 719 650 974 1174 1297 1516 1703
Other Income 11 10 8 10 10 19 31 37 51 44
Total Income 332 411 551 730 660 993 1204 1334 1567 1747
Total Expenditure 266 332 431 519 485 666 774 865 1022 1158
Operating Profit 66 79 120 211 175 327 430 469 545 588
Interest 3 4 6 48 46 56 58 63 77 77
Depreciation 22 28 37 69 73 83 90 112 138 151
Exceptional Income / Expenses 0 0 0 0 0 0 0 0 0 -2
Profit Before Tax 41 47 78 93 56 187 282 295 330 358
Provision for Tax 10 11 20 38 16 49 69 77 86 78
Profit After Tax 31 36 58 55 40 139 212 218 244 282
Adjustments 0 0 0 0 0 -0 -2 -1 -1 -2
Profit After Adjustments 31 36 58 56 40 138 211 217 243 278
Adjusted Earnings Per Share 3.4 4 6.4 6.2 4.4 14.7 20.8 21.4 24 27.4

RainbowChildrenS Med Balance Sheet

#(Fig in Cr.) Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Shareholder's Funds 329 362 416 405 446 603 1060 1259 1468
Minority's Interest 0 0 0 4 2 3 5 6 7
Borrowings 10 10 50 46 41 27 0 0 0
Other Non-Current Liabilities 4 5 7 472 468 526 541 730 722
Total Current Liabilities 56 70 86 171 122 125 139 149 151
Total Liabilities 399 448 559 1098 1078 1284 1745 2144 2347
Fixed Assets 174 296 344 702 772 858 931 1253 1398
Other Non-Current Assets 100 79 78 153 109 136 336 270 127
Total Current Assets 126 73 136 244 197 290 478 622 822
Total Assets 399 448 559 1098 1078 1284 1745 2144 2347

RainbowChildrenS Med Cash Flow

#(Fig in Cr.) Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Opening Cash & Cash Equivalents 4 5 3 5 7 6 10 17 10
Cash Flow from Operating Activities 36 48 90 170 143 224 329 321 396
Cash Flow from Investing Activities -33 -42 -117 -117 -83 -175 -465 -226 -268
Cash Flow from Financing Activities -1 -7 28 -52 -61 -44 143 -102 -118
Net Cash Inflow / Outflow 1 -2 2 2 -1 4 7 -7 10
Closing Cash & Cash Equivalent 5 3 5 7 6 10 17 10 20

RainbowChildrenS Med Ratios

# Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Earnings Per Share (Rs) 3.43 3.96 6.4 6.18 4.44 14.7 20.77 21.38 23.97
CEPS(Rs) 5.9 7.14 10.52 13.84 12.53 23.6 29.82 32.55 37.68
DPS(Rs) 2.5 1 1 2 0 2 3 3 3
Book NAV/Share(Rs) 35.24 38.93 44.88 43.77 48.32 62.93 104.42 123.08 144.41
Core EBITDA Margin(%) 17.1 17.3 20.61 27.9 25.4 31.61 34.05 33.34 32.6
EBIT Margin(%) 13.74 12.7 15.35 19.69 15.7 25.01 28.99 27.55 26.84
Pre Tax Margin(%) 12.84 11.64 14.3 12.98 8.57 19.24 24.01 22.73 21.77
PAT Margin (%) 9.76 9.03 10.67 7.69 6.09 14.24 18.1 16.83 16.11
Cash Profit Margin (%) 16.57 16.02 17.47 17.34 17.37 22.79 25.79 25.47 25.24
ROA(%) 7.86 8.57 11.51 6.68 3.64 11.74 14.02 11.23 10.87
ROE(%) 9.87 10.85 15.34 13.85 9.54 27 25.72 18.91 17.99
ROCE(%) 12.83 14.2 19.81 30.56 21.42 42.92 39.96 30.82 29.83
Receivable days 15.54 13.2 14.78 18.4 24.69 15.81 14.24 17.12 17.79
Inventory Days 7.65 5.78 4.36 5.83 7.32 4.67 5.22 6.01 6.21
Payable days 142.04 134.98 134.76 161.38 197.76 110.68 165.2 177.11 161.48
PER(x) 0 0 0 0 0 0 35.16 60.71 58.39
Price/Book(x) 0 0 0 0 0 0 6.99 10.55 9.69
Dividend Yield(%) 0 0 0 0 0 0 0.41 0.23 0.21
EV/Net Sales(x) -0.16 0.08 0.06 0.02 0.01 -0.04 6.28 10.15 9.36
EV/Core EBITDA(x) -0.8 0.41 0.25 0.06 0.03 -0.12 17.11 28.04 26.03
Net Sales Growth(%) 0 25.07 35.08 32.54 -9.64 49.8 20.52 10.51 16.88
EBIT Growth(%) 0 15.65 63.19 69.99 -27.93 138.58 39.69 5.05 13.84
PAT Growth(%) 0 15.74 59.67 -4.47 -28.5 250.47 53.15 2.78 11.88
EPS Growth(%) 0 15.65 61.61 -3.41 -28.19 231.04 41.3 2.93 12.12
Debt/Equity(x) 0.05 0.04 0.12 0.14 0.1 0.07 0 0 0
Current Ratio(x) 2.26 1.03 1.58 1.42 1.61 2.32 3.44 4.16 5.46
Quick Ratio(x) 2.14 0.95 1.5 1.33 1.53 2.2 3.31 4 5.28
Interest Cover(x) 15.25 11.96 14.64 2.93 2.2 4.34 5.83 5.71 5.3
Total Debt/Mcap(x) 0 0 0 0 0 0 0 0 0

Growth Rates

Compounded annual
# 1 Year 3 Year 5 Year 10 Year
Sales CAGR +17% +16% +16%
Operating Profit CAGR +16% +19% +21%
PAT CAGR +12% +21% +35%
Share Price CAGR -5% +12%
ROE Average +18% +21% +20% +17%
ROCE Average +30% +34% +33% +27%

RainbowChildrenS Med Shareholding Pattern

Latest · Mar 2026
100% held
Promoters 49.84 %
FII 17.24 %
DII (MF + Insurance) 21.13 %
Public (retail) 50.16 %
# Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026
Promoter 49.8349.8349.8849.8549.8549.8549.8549.8549.8449.84
FII 22.3224.0424.7825.1125.1223.6923.5921.8519.2317.24
DII 15.6214.7613.813.8313.8715.3115.4417.4619.4921.13
Public 50.1750.1750.1250.1550.1550.1550.1550.1550.1650.16
Others 0000000000
Total 100100100100100100100100100100

RainbowChildrenS Med Peer Comparison

Hospital & Healthcare Services Edit Columns

RainbowChildrenS Med Quarterly Price

10-year quarterly close · BSE
Show Value Show %

News & Updates

See more…

RainbowChildrenS Med Pros & Cons

Pros

  • Company has delivered good profit growth of 34% CAGR over last 5 years
  • Company has a good return on equity (ROE) track record: 3 Years ROE 21%
  • Debtor days have improved from 177.11 to 161.48days.
  • Company is almost debt free.

Cons

  • Promoter holding is low: 49.84%.
  • Stock is trading at 8.3 times its book value.
Want to Start Investing in Top Unlisted Stocks?

Our experts help you choose the right stocks based on performance, risk, and growth potential.

whatsapp